PASG Dividend: Passage Bio Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

PASG Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	22	24	41	49	60	30
Research & Development	31	40	61	89	125	82
Operating Expenses	61	65	102	138	185	112
Other Non Operating Income (Expenses)	1	1	0	--	--	--
Pretax Income	-56	-64	-102	-136	-185	-112
Income Tax Expense	--	--	--	--	--	--
Net Income	-56	-64	-102	-136	-185	-112
Net Income Growth	-26%	-37%	-25%	-26%	65%	149%
Shares Outstanding (Diluted)	3.16	3.02	2.73	2.72	2.66	1.93
Shares Change (YoY)	3%	10%	1%	2%	38%	-2%
EPS (Diluted)	-17.94	-21.44	-37.28	-50.02	-69.5	-58.12
EPS Growth	-28%	-42%	-25%	-28%	20%	151%
Free Cash Flow	-36	-47	-78	-123	-152	-82
Free Cash Flow Per Share	-11.36	-15.56	-28.49	-45.19	-56.98	-42.46
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-60	-62	-99	-135	-184	-112
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	1	3	3	3	1	0
EBIT	-61	-65	-102	-138	-185	-112
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--